TCL Archive Two Phase III Ramucirumab Trials Both Deliver Improved Overall and Progression-Free Survival October 25, 2013
TCL Archive ASCO Picks University of Michigan Medical School Dean Allen Lichter As Exective Vice President and CEO. July 14, 2006
TCL Archive Interferon Results Cool Expectations, But Other Reports At ASCO/AACR Demonstrate Solid Progress June 6, 1980
TCL Archive Upton Explains New NCI System: Rants Funded “Across The Board” Strictly By Priority Score August 25, 1978